Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.

Saved in:

Bibliographic Details
Title:	Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.
Authors:	Moyo-Gwete, Thandeka^1,2 (AUTHOR), Richardson, Simone I.^1,2 (AUTHOR), Keeton, Roanne^3,4 (AUTHOR), Hermanus, Tandile^1,2 (AUTHOR), Spencer, Holly^1,2 (AUTHOR), Manamela, Nelia P.^1,2 (AUTHOR), Ayres, Frances^1,2 (AUTHOR), Makhado, Zanele^1,2 (AUTHOR), Motlou, Thopisang^1,2 (AUTHOR), Tincho, Marius B.^3,4 (AUTHOR), Benede, Ntombi^3,4 (AUTHOR), Ngomti, Amkele^3,4 (AUTHOR), Baguma, Richard^3,4 (AUTHOR), Chauke, Masego V.^3,4 (AUTHOR), Mennen, Mathilda^5,6,7 (AUTHOR), Adriaanse, Marguerite^5,6,7 (AUTHOR), Skelem, Sango^5,6,7 (AUTHOR), Goga, Ameena⁸ (AUTHOR), Garrett, Nigel^9,10 (AUTHOR), Bekker, Linda-Gail^3,11 (AUTHOR)
Source:	PLoS Pathogens. 11/9/2023, Vol. 19 Issue 11, p1-19. 19p.
Database:	Academic Search Ultimate

Description
ISSN:	15537366
DOI:	10.1371/journal.ppat.1011772